Camtek (CAMT) Competitors $65.34 +0.34 (+0.52%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CAMT vs. RVTY, AVTR, BIO.B, NVMI, VNT, MIR, ST, TXG, TRNS, and CTKBShould you be buying Camtek stock or one of its competitors? The main competitors of Camtek include Revvity (RVTY), Avantor (AVTR), Bio-Rad Laboratories (BIO.B), Nova (NVMI), Vontier (VNT), Mirion Technologies (MIR), Sensata Technologies (ST), 10x Genomics (TXG), Transcat (TRNS), and Cytek Biosciences (CTKB). These companies are all part of the "measuring and control equipment" industry. Camtek vs. Revvity Avantor Bio-Rad Laboratories Nova Vontier Mirion Technologies Sensata Technologies 10x Genomics Transcat Cytek Biosciences Camtek (NASDAQ:CAMT) and Revvity (NYSE:RVTY) are both computer and technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, media sentiment, institutional ownership, community ranking, valuation, profitability and risk. Does the media favor CAMT or RVTY? In the previous week, Revvity had 28 more articles in the media than Camtek. MarketBeat recorded 37 mentions for Revvity and 9 mentions for Camtek. Camtek's average media sentiment score of 0.85 beat Revvity's score of 0.58 indicating that Camtek is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Camtek 3 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Revvity 15 Very Positive mention(s) 5 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, CAMT or RVTY? Camtek has a beta of 1.42, indicating that its stock price is 42% more volatile than the S&P 500. Comparatively, Revvity has a beta of 1.07, indicating that its stock price is 7% more volatile than the S&P 500. Does the MarketBeat Community believe in CAMT or RVTY? Camtek received 526 more outperform votes than Revvity when rated by MarketBeat users. Likewise, 71.25% of users gave Camtek an outperform vote while only 62.96% of users gave Revvity an outperform vote. CompanyUnderperformOutperformCamtekOutperform Votes56071.25% Underperform Votes22628.75% RevvityOutperform Votes3462.96% Underperform Votes2037.04% Is CAMT or RVTY more profitable? Camtek has a net margin of 27.61% compared to Revvity's net margin of 9.81%. Camtek's return on equity of 24.99% beat Revvity's return on equity.Company Net Margins Return on Equity Return on Assets Camtek27.61% 24.99% 14.81% Revvity 9.81%7.68%4.62% Which has better valuation & earnings, CAMT or RVTY? Revvity has higher revenue and earnings than Camtek. Camtek is trading at a lower price-to-earnings ratio than Revvity, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCamtek$429.23M6.94$118.51M$2.4227.00Revvity$2.76B4.07$270.39M$2.2142.24 Do insiders & institutionals have more ownership in CAMT or RVTY? 41.9% of Camtek shares are held by institutional investors. Comparatively, 86.7% of Revvity shares are held by institutional investors. 79.4% of Camtek shares are held by company insiders. Comparatively, 0.7% of Revvity shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Is CAMT or RVTY a better dividend stock? Camtek pays an annual dividend of $1.33 per share and has a dividend yield of 2.0%. Revvity pays an annual dividend of $0.28 per share and has a dividend yield of 0.3%. Camtek pays out 55.0% of its earnings in the form of a dividend. Revvity pays out 12.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Do analysts rate CAMT or RVTY? Camtek currently has a consensus target price of $103.13, indicating a potential upside of 57.83%. Revvity has a consensus target price of $126.46, indicating a potential upside of 35.48%. Given Camtek's stronger consensus rating and higher possible upside, equities analysts plainly believe Camtek is more favorable than Revvity.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Camtek 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.00Revvity 0 Sell rating(s) 4 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 2.79 SummaryCamtek beats Revvity on 13 of the 20 factors compared between the two stocks. Get Camtek News Delivered to You Automatically Sign up to receive the latest news and ratings for CAMT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CAMT vs. The Competition Export to ExcelMetricCamtekOptical instruments & lenses IndustryComputer SectorNASDAQ ExchangeMarket Cap$2.98B$12.75B$23.07B$7.82BDividend Yield2.25%1.62%2.98%4.22%P/E Ratio27.0038.7942.1618.48Price / Sales6.946.522,077.08103.91Price / Cash39.5320.2234.7234.62Price / Book5.406.156.124.25Net Income$118.51M$324.03M$738.82M$248.23M7 Day Performance2.14%4.21%3.50%3.29%1 Month Performance10.75%1.39%2.00%2.43%1 Year Performance-19.30%-2.61%52,547.40%5.54% Camtek Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CAMTCamtek3.6822 of 5 stars$65.34+0.5%$103.13+57.8%-21.4%$2.98B$429.23M27.00400RVTYRevvity3.8606 of 5 stars$95.00+0.8%$130.50+37.4%-9.8%$11.41B$2.76B42.9916,700Earnings ReportDividend AnnouncementAnalyst ForecastAnalyst RevisionNews CoverageHigh Trading VolumeAVTRAvantor4.6439 of 5 stars$12.49-3.4%$19.32+54.7%-47.3%$8.51B$6.78B12.0114,500Earnings ReportAnalyst DowngradeNews CoverageHigh Trading VolumeBIO.BBio-Rad LaboratoriesN/A$234.41flatN/A-16.3%$6.57B$2.57B-3.608,200NVMINova3.0252 of 5 stars$196.04-0.3%$264.60+35.0%+11.8%$5.74B$672.40M34.151,180Positive NewsVNTVontier4.2529 of 5 stars$31.40+0.3%$43.17+37.5%-24.6%$4.66B$2.98B11.428,100Upcoming EarningsPositive NewsMIRMirion Technologies1.7672 of 5 stars$15.40+0.5%$18.75+21.8%+41.4%$3.58B$860.80M-81.052,870Earnings ReportNews CoverageSTSensata Technologies4.8994 of 5 stars$21.36+0.3%$33.33+56.1%-40.1%$3.19B$3.93B25.4320,800Positive NewsTXG10x Genomics4.6617 of 5 stars$8.48+2.2%$19.79+133.3%-70.5%$1.04B$610.79M-5.581,240News CoveragePositive NewsGap DownTRNSTranscat2.7107 of 5 stars$80.98-4.9%$111.50+37.7%-27.4%$753.84M$272.20M43.77920News CoveragePositive NewsCTKBCytek Biosciences2.5765 of 5 stars$3.86+2.4%$6.42+66.2%-37.8%$494.45M$200.45M-48.24500Upcoming Earnings Related Companies and Tools Related Companies Revvity Alternatives Avantor Alternatives Bio-Rad Laboratories Alternatives Nova Alternatives Vontier Alternatives Mirion Technologies Alternatives Sensata Technologies Alternatives 10x Genomics Alternatives Transcat Alternatives Cytek Biosciences Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CAMT) was last updated on 4/30/2025 by MarketBeat.com Staff From Our Partners"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Camtek Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Camtek With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CAMT Stock Free CAMT Stock Alerts